0001209191-21-041091.txt : 20210616 0001209191-21-041091.hdr.sgml : 20210616 20210616190129 ACCESSION NUMBER: 0001209191-21-041091 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210614 FILED AS OF DATE: 20210616 DATE AS OF CHANGE: 20210616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Butt Tausif CENTRAL INDEX KEY: 0001845266 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35420 FILM NUMBER: 211022814 MAIL ADDRESS: STREET 1: C/O CHEMOCENTRYX, INC. STREET 2: 850 MAUDE AVE. CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ChemoCentryx, Inc. CENTRAL INDEX KEY: 0001340652 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943254365 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 650-210-2900 MAIL ADDRESS: STREET 1: 835 INDUSTRIAL ROAD STREET 2: SUITE 600 CITY: SAN CARLOS STATE: CA ZIP: 94070 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-06-14 0 0001340652 ChemoCentryx, Inc. CCXI 0001845266 Butt Tausif C/O CHEMOCENTRYX, INC. 835 INDUSTRIAL ROAD, SUITE 600 SAN CARLOS CA 94070 0 1 0 0 EVP, Chief Operating Officer Stock Option (right to buy) 13.17 2021-06-14 4 A 0 75000 A 2031-06-14 Common Stock 75000 75000 D The option was granted on June 14, 2021, and 25% of the total number of shares of common stock subject to the option vests on June 14, 2022, and 1/48th of the total number of shares of common stock subject to the option vests monthly thereafter, subject to the Reporting Person's continued service to the Company on each such vesting date. Not applicable. /s/ Susan M. Kanaya, as Attorney-in-Fact 2021-06-16